Search research articles
Contact Us
Filters
Showing results (21-30 of 47) with videos related to
Page
of 5
Sort By:
Blood
|
August 1, 1995
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
A Nademanee, G M Schmidt, P Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients
M R O'Donnell, G M Schmidt, B R Tegtmeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia
M R O'Donnell, G D Long, P M Parker, et al.
Blood
|
December 9, 2000
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program
S M Davies, C Kollman, C Anasetti, et al.
Blood
|
March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
A Nademanee, M R O'Donnell, D S Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells
A Nademanee, I Sniecinski, G M Schmidt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2009
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation
V Pullarkat, M L Slovak, A Dagis, et al.
Bone Marrow Transplantation
|
June 9, 2009
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD
R Rodriguez, A Nademanee, J M Palmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Solid cancers after bone marrow transplantation
S Bhatia, A D Louie, R Bhatia, et al.
Bone Marrow Transplantation
|
September 25, 2012
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant
S K Khaled, J Palmer, T Stiller, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 47) with videos related to
Sort By:
Page
of 5
Blood
|
August 1, 1995
The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone
A Nademanee, G M Schmidt, P Parker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients
M R O'Donnell, G M Schmidt, B R Tegtmeier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 1995
Busulfan/cyclophosphamide as conditioning regimen for allogeneic bone marrow transplantation for myelodysplasia
M R O'Donnell, G D Long, P M Parker, et al.
Blood
|
December 9, 2000
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program
S M Davies, C Kollman, C Anasetti, et al.
Blood
|
March 1, 1995
High-dose chemotherapy with or without total body irradiation followed by autologous bone marrow and/or peripheral blood stem cell transplantation for patients with relapsed and refractory Hodgkin's disease: results in 85 patients with analysis of prognostic factors
A Nademanee, M R O'Donnell, D S Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1994
High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells
A Nademanee, I Sniecinski, G M Schmidt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2009
Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation
V Pullarkat, M L Slovak, A Dagis, et al.
Bone Marrow Transplantation
|
June 9, 2009
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD
R Rodriguez, A Nademanee, J M Palmer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2001
Solid cancers after bone marrow transplantation
S Bhatia, A D Louie, R Bhatia, et al.
Bone Marrow Transplantation
|
September 25, 2012
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant
S K Khaled, J Palmer, T Stiller, et al.
Page
of 5